Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$567M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$503M |
| 3 |
Netflix
NFLX
|
+$499M |
| 4 |
Bausch Health
BHC
|
+$323M |
| 5 |
MON
Monsanto Co
MON
|
+$314M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$967M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$840M |
| 3 |
Valero Energy
VLO
|
+$436M |
| 4 |
Capri Holdings
CPRI
|
+$368M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Communication Services | 12% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Financials | 9.77% |
| 5 | Energy | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
| $1.49B | 6.52% |
20,137,154
-3,968,687
| -16% | -$277M |
|
|
2
Bausch Health
BHC
$2.41B
| $1.49B | 6.51% |
11,830,932
+2,534,789
| +27% | +$323M |
|
3
Illumina
ILMN
$33.1B
| $1.43B | 6.23% |
8,216,644
-897,856
| -10% | -$134M |
|
4
Lowe's Companies
LOW
$121B
| $1.1B | 4.8% |
22,907,968
+4,795,400
| +26% | +$224M |
|
5
LyondellBasell Industries
LYB
$21.8B
| $1.05B | 4.59% |
10,771,736
-2,087,268
| -16% | -$199M |
|
6
Thermo Fisher Scientific
TMO
$233B
| $976M | 4.26% |
8,271,280
-1,397,359
| -14% | -$164M |
|
|
PXD
7
DELISTED
Pioneer Natural Resource Co.
PXD
| $936M | 4.09% |
4,072,836
+2,435,300
| +149% | +$503M |
|
8
Baidu
BIDU
$31.6B
| $875M | 3.82% |
4,681,428
+442,470
| +10% | +$72.4M |
|
9
Capital One
COF
$134B
| $840M | 3.67% |
10,165,787
-734,630
| -7% | -$57.1M |
|
|
10
Regeneron Pharmaceuticals
REGN
$85.9B
| $837M | 3.65% |
2,963,456
+1,911,656
| +182% | +$567M |
|
11
Mastercard
MA
$509B
| $722M | 3.15% |
9,820,830
+2,088,010
| +27% | +$155M |
|
|
MON
12
DELISTED
Monsanto Co
MON
| $721M | 3.15% |
5,780,631
+2,683,100
| +87% | +$314M |
|
13
Mohawk Industries
MHK
$9.23B
| $629M | 2.74% |
4,543,823
+2,030,935
| +81% | +$274M |
|
14
Mondelez International
MDLZ
$82.3B
| $598M | 2.61% |
15,898,877
+586,202
| +4% | +$21.4M |
|
15
Micron Technology
MU
$1.09T
| $583M | 2.55% |
17,699,068
-2,968,549
| -14% | -$80.9M |
|
|
16
Netflix
NFLX
$331B
| $580M | 2.53% |
+92,226,190
| New | +$499M |
|
17
Visa
V
$693B
| $578M | 2.52% |
10,978,612
-3,992
| -0% | -$209K |
|
|
TWX
18
DELISTED
Time Warner Inc
TWX
| $553M | 2.41% |
7,872,453
-14,708,031
| -65% | -$967M |
|
19
Canadian Pacific Kansas City
CP
$85B
| $544M | 2.38% |
15,021,210
-5,094,025
| -25% | -$167M |
|
|
TFCFA
20
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $465M | 2.03% |
13,229,932
-24,703,924
| -65% | -$840M |
|
|
SLXP
21
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $356M | 1.56% |
2,889,303
+1,337,537
| +86% | +$148M |
|
|
CAM
22
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $331M | 1.45% |
4,889,535
-2,921,684
| -37% | -$188M |
|
|
KSU
23
DELISTED
Kansas City Southern
KSU
| $326M | 1.42% |
3,027,831
+1,190,206
| +65% | +$123M |
|
|
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
| $313M | 1.37% |
2,006,092
+169,434
| +9% | +$26.8M |
|
25
Constellation Brands
STZ
$23.2B
| $292M | 1.27% |
3,308,832
-3,705,306
| -53% | -$306M |
|
Similar funds
Andreas Halvorsen's Q2 2014 Portfolio in Review
As of Q2 2014, Andreas Halvorsen held 80 positions worth $22.9B, down 3.9% from $23.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Andreas Halvorsen withdrew a net $2.63B in Q2 2014, closing 18 positions and reducing 25 holdings. Its most notable exit was American International, an estimated $316M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Andreas Halvorsen opened a new position in Netflix worth $580M.
- Andreas Halvorsen's largest Q2 2014 buy was Netflix: 92,226,190 shares worth $580M.
- Andreas Halvorsen added most to Regeneron Pharmaceuticals in Q2 2014, an estimated $567M increase.
- Andreas Halvorsen's biggest Q2 2014 reduction was Time Warner Inc, cutting an estimated $967M.
- Andreas Halvorsen fully exited American International in Q2 2014, selling an estimated $316M.
- Andreas Halvorsen's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2014.
- Andreas Halvorsen opened 20 new positions and closed 18 in Q2 2014.
- Andreas Halvorsen's portfolio value fell 3.9% quarter-over-quarter to $22.9B.
Based on Viking Global Investors's 13F filing for Q2 2014, filed 14 Aug 2014.